Progranulin Protects Against Osteonecrosis of the Femoral Head by Activating ERK1/2 Pathway

被引:18
|
作者
Han, Yingguang [1 ]
Si, Meng [1 ]
Zhao, Yunpeng [1 ]
Liu, Yi [1 ]
Cheng, Kaiyuan [1 ]
Zhang, Yuedong [2 ]
Jia, Jialin [1 ]
Li, Jingkun [3 ]
Nie, Lin [1 ]
机构
[1] Shandong Univ, Qilu Hosp, Dept Orthopaed Surg, 107,Wen Hua Xi Rd, Jinan 250012, Shandong, Peoples R China
[2] Taian Cent Hosp, Dept Orthopaed Surg, Tai An 271000, Shandong, Peoples R China
[3] Shandong Univ, Shandong Prov Qianfoshan Hosp, Dept Orthopaed Surg, 16766,Jingshi Rd, Jinan 250014, Shandong, Peoples R China
关键词
progranulin; osteonecrosis; ERK; TNF-alpha; GRANULIN-EPITHELIN PRECURSOR; EARLY-DIAGNOSIS; GROWTH-FACTOR; BONE; NECROSIS; EXPRESSION; MUTATIONS; ADAMTS-7; ELASTASE; TARGET;
D O I
10.1007/s10753-017-0539-z
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The aim of this study was to investigate progranulin (PGRN) expression and its effect in cartilage degradation and in the pathogenesis of osteonecrosis of the femoral head (ONFH). Cartilage specimens were obtained from ONFH and FNF patients and PGRN expression was analyzed by immunohistochemistry, western blot analysis, and RT-PCR. Peripheral blood PGRN level was detected by ELISA. Additionally, primary chondrocytes were cultured and treated with PGRN. Next, the expression of aggrecan and collagen II and the activation of ERK1/2 were detected. We observed that the expression of PGRN was significantly upregulated in ONFH patients' articular cartilage, and recombinant PGRN could promote expression of aggrecan and collagen II and the activation of ERK1/2. Collectively, PGRN can improve chondrocyte anabolism and perform a therapeutic role in the pathogenesis of ONFH. This study helps to elucidate the pathogenesis of ONFH and presents PGRN as a potential target for the treatment of ONFH.
引用
收藏
页码:946 / 955
页数:10
相关论文
共 50 条
  • [1] Progranulin Protects Against Osteonecrosis of the Femoral Head by Activating ERK1/2 Pathway
    Yingguang Han
    Meng Si
    Yunpeng Zhao
    Yi Liu
    Kaiyuan Cheng
    Yuedong Zhang
    Jialin Jia
    Jingkun Li
    Lin Nie
    Inflammation, 2017, 40 : 946 - 955
  • [2] Desferoxamine protects against glucocorticoid-induced osteonecrosis of the femoral head via activating HIF-1α expression
    Jing, Xingzhi
    Du, Ting
    Yang, Xiaoxia
    Zhang, Weimin
    Wang, Guodong
    Liu, Xiaoyang
    Li, Tao
    Jiang, Zhensong
    JOURNAL OF CELLULAR PHYSIOLOGY, 2020, 235 (12) : 9864 - 9875
  • [3] Postconditioning Protects Against Reperfusion Injury in Hypertensive Dilated Cardiomyopathy by Activating MEK/ERK1/2 Signaling
    Hernandez-Resendiz, Sauri
    Roldan, Francisco-Javier
    Correa, Francisco
    Martinez-Abundis, Eduardo
    Osorio-Valencia, Gabriel
    Ruiz-de-Jesus, Oscar
    Alexanderson-Rosas, Erick
    Vigueras, Rosa M.
    Franco, Martha
    Zazueta, Cecilia
    JOURNAL OF CARDIAC FAILURE, 2013, 19 (02) : 135 - 146
  • [4] TRAIL: Activation of ERK1/2 protects cells against apoptosis
    Cremer, M
    CANCER INVESTIGATION, 2005, 23 (07) : 651 - 651
  • [5] Kanglexin protects against cardiac fibrosis and dysfunction in mice by TGF-β1/ERK1/2 noncanonical pathway
    Liu, Xue
    Han, Weina
    An, Na
    Cao, Na
    Wu, Tingting
    Yang, Shuang
    Ding, Lili
    Chen, Xiaoli
    Chen, Chao
    Aruhan
    Zhang, Yannan
    Wang, Kexin
    Suo, Lianhuan
    Huang, Jian
    Wang, Jinhui
    Zhao, Xin
    Zhu, Jiuxin
    Zhang, Yan
    Yang, Baofeng
    FRONTIERS IN PHARMACOLOGY, 2021, 11
  • [6] Icariin Protects against Glucocorticoid-Induced Osteonecrosis of the Femoral Head in Rats
    Huang, Zengfa
    Cheng, Cheng
    Cao, Beibei
    Wang, Jing
    Wei, Hui
    Liu, Xianzhe
    Han, Yu
    Yang, Shuhua
    Wang, Xiang
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2018, 47 (02) : 694 - 706
  • [7] Increasing progranulin levels and blockade of the ERK1/2 pathway: Upstream and downstream strategies for the treatment of progranulin deficient frontotemporal dementia
    Alquezar, Carolina
    Esteras, Noemi
    de la Encarnacion, Ana
    Moreno, Fermin
    Lopez de Munain, Adolfo
    Martin-Requero, Angeles
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2015, 25 (03) : 386 - 403
  • [8] Tissue kallikrein protects cortical neurons against hypoxia/reoxygenation injury via the ERK1/2 pathway
    Liu, Ling
    Liu, Haibo
    Yang, Fang
    Chen, Guanghui
    Zhou, Houguang
    Tang, Min
    Zhang, Renliang
    Dong, Qiang
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2011, 407 (02) : 283 - 287
  • [9] Sufentanil protects the rat myocardium against ischemia–reperfusion injury via activation of the ERK1/2 pathway
    Hui Tao
    Min Nuo
    Su Min
    Cytotechnology, 2018, 70 : 169 - 176
  • [10] DiOHF Protects Against Doxorubicin-Induced Cardiotoxicity Through ERK1 Signaling Pathway
    Chang, Danqi
    Li, Hang
    Qian, Cheng
    Wang, Yanggan
    FRONTIERS IN PHARMACOLOGY, 2019, 10